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Abstract
Background: Status epilepticus (SE) is a severe condition that may lead to hippocampal cell loss and epileptogenesis.
Some of the mechanisms associated with SE-induced cell death are excitotoxicity, neuroinflammation, and apoptosis.
Objective: The objective of the present study is to test the hypothesis that DBS has anti-inflammatory and antiapoptotic
effects when applied during SE.
Methods: Rats undergoing pilocarpine-induced SE were treated with anterior thalamic nucleus (AN) deep brain
stimulation (DBS). Inflammatory changes and caspase 3 activity were measured within 1 week of treatment.
Results: In pilocarpine-treated rats, DBS countered the significant increase in hippocampal caspase 3 activity and
interleukin-6 (IL-6) levels that follows SE but had no effect on tumor necrosis factor α (TNFα).
Conclusions: DBS has anti-inflammatory and antiapoptotic effects when given to animals undergoing status.
Keywords: Anterior thalamic nucleus, Thalamus, Seizures, Deep brain stimulation, Epilepsy, Apoptosis,
Neuroprotection, Caspase
Status epilepticus (SE) is a condition associated with con-
tinuous seizure activity that often leads to excitotoxicity
and cell death [1]. Deep brain stimulation (DBS) of the
anterior thalamic nucleus (AN), an approved treatment for
medically refractory partial epilepsy [2], has been shown to
reduce seizure rate and increase the latency for the devel-
opment of SE in different rodent models [3–6]. To date,
whether stimulation is protective against SE-induced
excitotoxicity is largely unknown.
In Parkinson’s disease, subthalamic nucleus DBS has
been proposed to induce neuroprotective effects by redu-
cing the glutamatergic drive to the substantia nigra [7]. In
a parallel scenario, AN stimulation inhibits the spontan-
eous activity of local neuronal populations and reduces
the firing rate of dentate gyrus cells [8]. Following this line
of reasoning, we hypothesize that a decreased drive to the
hippocampus following AN DBS could have neuroprotec-
tive effects.
In preclinical models [9] and in the clinic [10, 11],
neuromodulation treatments that induce antiepileptic ef-
fects, such as vagus nerve stimulation (VNS), have been
shown to reduce plasmatic levels of cytokines.
In the present study, we test the hypothesis that AN
DBS reduces hippocampal apoptosis and neuroinflamma-
tion in rats undergoing pilocarpine (Pilo)-induced SE.
Methods
Ethics, consent, and permissions
Experiments were approved by the Animal Care committee
of the Universidade Federal de São Paulo (1482/11).
Pilocarpine administration and AN stimulation
Male Wistar rats (~250 g) were anesthetized with keta-
mine/xylazine (100/7.5 mg/kg i.p.) and had insulated
stainless steel electrodes (cathodes; 250-μm diameter;
0.5-mm exposed surface) bilaterally implanted into the
AN (anteroposterior −1.5, lateral ± 1.5, depth 5.2) [12]. A
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screw implanted over the right somatosensory cortex
was used as the anode. Control animals had holes
drilled into the skull but were not implanted with elec-
trodes. Animals undergoing electroencephalography
(EEG) recordings were implanted with bipolar cortical
electrodes (Plastics One; 3 mm posterior, 4 mm lateral, and
2 mm ventral to the bregma) [12]. One week later, animals
received N-methyl-scopolamine (1 mg/kg s.c. Sigma, St
Louis, MO) followed, 30 min later, by pilocarpine
(320 mg/kg, i.p., Vegeflora, Brazil). SE was characterized
by the presence of uninterrupted behavioral seizures [24].
As pilocarpine-induced seizures often last a few seconds,
DBS was commenced 1 minute after SE onset. Stimulation
settings were in the range of those used in our previous
studies: 130 Hz, 90 μs, and 400 μA (St Jude MTS, Plano,
TX) [3].
Ninety minutes after SE, the animals received thionem-
butal (30 mg/kg) to attenuate behavioral status and reduce
mortality rate. As animals began to recover 6 h later, DBS
was delivered continuously during the first 6 h of status.
EEG was recorded with a BNT-36 system (Lynx, Brazil)
using the ENSA software (ENSA, Brazil) for 24 h from the
moment Pilo was injected. Signals were amplified, band
pass filtered (0.1–30 Hz), and digitized (200 samples/s).
Complex Gaussian’s wavelet transform analysis was used
to investigate the signals in the frequency domain.
Placement of DBS electrodes was confirmed in cresyl-
violet-stained sections and was similar to that described
in our previous reports [13].
Caspase 3 and cytokine measurements
After removal from the skull, the brains were split in half,
and the hippocampus of each hemisphere was dissected.
The left hippocampus was used for the study of caspase
activity. The right hippocampus was used to measure
cytokines.
The hippocampus of each animal was incubated with a
homogenization buffer and mechanically homogenized, as
previously described [14]. Samples were centrifuged for
40 min, and the total protein content in the supernatant
determined using the Bio-Rad Protein Assay, according to
the manufacturer’s specification (Bio-Rad Labs, Germany).
Measurement of caspase 3 activity was obtained using the
caspase 3 fluorimetric assay kit (CASP3F, Sigma, USA).
Triplicates of each sample (all containing 100 mg of
protein) were analyzed. All received the substrate but
only one the inhibitor. Activity was measured continu-
ously over 5 h on a FlexStation 3 Spectrofluorimeter
(Molecular Probes, USA), using λex = 360 nm and λem =
465 nm. Values obtained from samples containing the in-
hibitor were subtracted from those recorded from the
other samples, and the arithmetic average was calculated.
After calibration for AMC, results were expressed as nMol
AMC.
For cytokine detection, the right hippocampus was
homogenized in 0.01 M Tris hydrochloride (pH 7.6) con-
taining 5.8 % sodium chloride, 10 % glycerol, 1 % Nonidet
P40 (NP-40), 0.4 % of ethylenediamine tetraacetic acid
(EDTA), and protease inhibitors. Samples were sonicated
and stored at −80 °C. Subsequently, samples were centri-
fuged for 5 min. at 10,000 × g at 4 °C, and concentrations
determined with a Millipore multiplex Rat Cytokine Kit
(RECYTMAG-65K-03) on the Luminex® xMAP® platform
(xPonent/Analyst Software version 4.2). Longitudinal con-
trols were used to assess inter-assay variability. Results are
expressed in pg/mg.
Statistical analysis
Two-way ANOVA (DBS and Pilo as main factors; Tukey
post hoc) was used to compare neurochemical data.
Electrophysiological results were analyzed with Wilcoxon
signed-rank test. Values in the text represent mean ± SEM.
Results
Apoptosis and neuroinflammatory changes
Hippocampal caspase 3 activity was studied 7 days follow-
ing SE, a time frame during which apoptosis reaches
maximal levels [15, 16]. At this time point, we found sig-
nificant Pilo (F(1,16) = 17.17; P = 0.0008) and DBS effects
(F(1,16) = 10.34; P = 0.005). As can be seen in Fig. 1, caspase
3 activity was increased in pilocarpine-treated rats (n = 5)
as compared to saline-injected controls (n = 5; P = 0.009).
The administration of DBS significantly reduced such
activity (n = 5), bringing it to a level that was similar to
that of non-epileptic controls (n = 5; P = 0.02 vs Pilo). In
contrast, no significant Pilo (F(1,16) = 0.01; P = 0.95) or
DBS effects (F(1,16) = 1.97; P = 0.18) were recorded when
caspase 3 activity was measured 24 h following status epi-
lepticus (Additional file 1: Figure S1; n = 5 animals/group).
Markers of inflammatory activity were studied 1 day
following status, when post-SE changes are at high levels
[17, 18]. Hippocampal pro-inflammatory IL-6 was influ-
enced by both Pilo (F(1,14) = 9.85; P = 0.007) and DBS
(F(1,14) = 9.23; P = 0.008) with interaction between both
factors (F(1,14) = 4.53; P = 0.05). Overall, levels of this
interleukin were slightly reduced in AN DBS control an-
imals, a response that was further evidenced after status
(P = 0.002 vs Pilo) (Fig. 1). Although TNFα levels were in
the lower limit of the detection of the fluorimetric assay,
these were found to be influenced by Pilo (F(1,14) = 22.60;
P = 0.0003) but not DBS.
To investigate whether the protective effects of DBS were
due to a decrease in SE severity, EEG recordings were
obtained before and during status (n = 5 per group).
Though tracings looked similar between groups, spectral
analysis revealed that animals receiving DBS had a signifi-
cant decrease in alpha and beta band peaks (Additional
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file 2: Figure S2). This suggests that DBS may potentially
decrease SE severity.
Discussion
It is well established that seizures and SE can activate
intrinsic and extrinsic apoptotic pathways leading to
neuronal death. As a common final step, caspase 3 ac-
tivation invariably leads to an irreversible apoptotic
process. In rodents, caspase 3 is active 24–72 h follow-
ing status but maximally expressed 7 days later [19].
Our results suggest that animals given DBS during sta-
tus had a significant decrease in hippocampal caspase 3
activity, as measured by a commercial protein assay.
While this method was reliable and showed low
variability across animals, it did not allow us to deter-
mine in which hippocampal subregions apoptosis was
occurring. In a preliminary immunohistochemistry ex-
periment (unpublished data), we found that animals
undergoing SE with or without DBS had caspase-3-
expressing cells in the dentate gyrus, CA1, and CA3
subfields. This technique, however, has only shown
sparsely stained cells and a great variability across rats.
Whether the effects of DBS are related to a decrease in
apoptotic processes or a lower number of hippocampal
cells undergoing cell death remains to be elucidated.
Another technical aspect that needs to be discussed is
the choice of a control group without electrodes implanted.
This was based on our previous studies showing that elec-
trode insertion did not influence the latency for developing
SE or the frequency of seizures in pilocarpine-treated rats
[3, 20]. Placement of electrodes in the brain often causes a
mild local inflammatory response that tends to subside
over time. Though it is possible that this might have oc-
curred in the AN, samples in our study were collected at a
distance from the target (i.e., in the hippocampus and not
in the AN). In addition, an inflammatory response should
have theoretically increased pro-inflammatory cytokines. In
our study, DBS-treated animals had the opposite effect.
Most cells in the AN are immunocytochemically posi-
tive for glutamate and aspartate [21]. Connections be-
tween the AN and hippocampus are both direct (e.g., via
subiculum and CA1) and indirect (i.e., via anterior cingu-
lum and entorhinal cortex) [22, 23]. In our previous work,
AN DBS was shown to induce a strong depolarization
block of local neuronal populations and reduce the firing
in hippocampal dentate gyrus cells [24]. Bearing this in
mind, it is possible that reduced activity within the AN
complex and DG following DBS might have decreased
glutamate-induced excitotoxicity, reducing hippocam-
pal caspase activity and inflammatory responses. This,
however, still needs to be demonstrated.
Another possibility to explain potential neurochemical
differences between animals that did or did not receive
DBS is that stimulation might have influenced SE severity.
Though EEG tracings looked similar between groups, a
more detailed spectral analysis revealed that the rats given
DBS had a decrease in alpha and beta power. This may
represent a milder form of status epilepticus, as the with-
drawal of anticonvulsant medications may enhance beta
rhythms during continuous seizures [25].
One limitation of the current study is that we cannot infer
a direct association between reduced excitotoxicity, anti-
Fig. 1 DBS, apoptosis, and neuroinflammation. (a) Hippocampal caspase 3 activity was increased in pilocarpine-treated rats undergoing SE (P = 0.009;
vs saline controls), an effect that was significantly reversed in the DBS-treated Pilo group (P = 0.02; vs Pilo). Similarly (b), hippocampal levels
of the pro-inflammatory IL-6 were significantly increased after SE (P = 0.006; vs saline-injected controls), an effect that was countered by the adminis-
tration of AN DBS (P = 0.02; vs Pilo). In contrast, SE-induced increases in TNFα (P = 0.0003 vs saline-injected controls) were not influenced by DBS (c). #
indicates differences from control, *indicates differences from Pilo
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inflammatory, and antiapoptotic effects of DBS. Similarly,
we are unable to explain why DBS has only influenced cer-
tain pro-inflammatory cytokines (i.e., IL-6 but not TNFα).
Conclusion
As excitotoxicity and inflammatory responses are early
occurring events following SE, we postulate that the
reduced levels of apoptosis observed after DBS may be
due, at least in part, to its anti-inflammatory effects.
That said, our results do not allow one to establish a
causal relationship between a DBS-induced reduction
in cytokines and apoptosis, an aspect that needs to be
investigated in the future.
Additional files
Additional file 1: Figure S1. Apoptosis 24 h after pilocarpine-induced
status epilepticus. No significant differences were found in hippocampal
caspase 3 activity when animals who developed pilocarpine-induced SE
with or without DBS were compared to controls. (TIFF 94 kb)
Additional file 2: Figure S2. EEG activity recorded before and during SE
in animals that did and did not receive DBS. (A) Traces of a non-stimulated
animal before (left) and during (right) SE. Spectral arrays after wavelet
transform of corresponding EEG traces show activity in the α and β bands
during SE. (B) Traces of a DBS-treated animal before (left) and during (right)
SE. Spectral arrays after wavelet transform of the corresponding EEG traces
show that activity during SE in the α and β bands are reduced during AN
DBS. (C) Box plot showing the mean power spectrum of different frequency
bands pre-SE in animals that did not (yellow bars) or did receive AN DBS
(blue bars). As stimulation was not turned on at that point, Wilcoxon
signed-rank test showed no significant difference between groups (P> 0.05,
n= 5). (D) Box plot showing the mean power spectrum of different frequency
bands during SE without (yellow bars) and with AN DBS (blue bars). Wilcoxon
signed-rank test showed significant differences between groups in the α and
β bands (P < 0.05, n= 5 animals/group). (TIFF 2135 kb)
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